IP Library Granted Patent US 8,084,243
Granted Patent B2
US 8,084,243 · App. 12/196,164 · Granted Dec 27, 2011

Blocking sporulation by inhibiting SpoIIE

Assignee: William Marsh Rice University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,243
App. No.
12/196,164
Granted
Dec 27, 2011
Kind
B2
Abstract

We have shown that the control of solventogenesis and sporulation can be genetically uncoupled in C. acetobutylicum . In strain 824(pASspo), the absence of SpoIIE causes sporulation to be blocked at stage II. The cell remains in a vegetative state, and this allows solvent production to proceed for longer and for solvents to accumulate more rapidly and to a higher concentration. The characteristic drop in OD600 observed in wild type and control strains of C. acetobutylicum after 48-72 hours as the cells transition from the solventogenic phase to sporulation is notably absent in the fermentations of 824(pASspo). Mutant S (wild type background, spoIIE disrupted), Mutant BS (Mutant B background, spoIIE disrupted), Mutant HS (Mutant H background, spoIIE disrupted) and Mutant bukS (buk- background, spoIIE disrupted) were generated to create stable solvent producing bacteria with complete inactivation of the SpoIIE protein. Similarity between the SpoIIE protein of C. acetobutylicum, B. subtilis , and other Clostridial species indicates that the techniques used in C. acetobutylicum can be applied to other solvent producing Clostridia.

Claims (9)

1. A recombinant solvent producing Clostridium , said Clostridium being a Clostridium acetobutylicum and having a SpoIIE gene disruption sufficient to inhibit sporulation and wherein said SpoIIE disruption increases the production of ethanol, acetone, and/or butanol.

2. The solvent producing Clostridium strain of claim 1 , wherein said disruption is constructed from the SpoIIE gene of SEQ ID NO: 1.

3. The solvent producing Clostridium strain of claim 1 , wherein said disruption is selected from the group consisting of a mutation, deletion, and interruption of the SpoIIE gene.

4. The solvent producing Clostridium strain of claim 1 , wherein said disruption is mutation of a conserved SpoIIE residue.

5. The solvent producing Clostridium strain of claim 1 , wherein said disruption is a mutation of a conserved residue selected from the group consisting of asp-610, asp-628, asp-746, gly-747 and asp-795, wherein the amino acids are numbered with reference to SEQ ID NO: 26 as numbered in FIG. 7 .

6. A method for producing an organic solvent comprising:

a) culturing the solvent producing strain of Clostridium of any of claims 1 to 5 under conditions suitable for solventogenesis in order to generate a culture media; and

b) purifying an organic solvent from said culture media.

7. The method of claim 6 , wherein said organic solvent is ethanol, acetone, butanol or combinations thereof.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 10, 2012
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028185/0538 →
Continuity (3)
Division 11173542 · Jul 1, 2005
Provisional Application 60584727 · Jul 1, 2004
Related Publication 20090093035A1 · Apr 9, 2009